back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-10-07 16:30 Tx date 2025-09-30 |
$HLS
HLS Therapeutics Inc. |
Hill, Rodney Graham
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$17,398
+3,246 vol $5.36 each |
112,438 | |
| Filed 2025-10-07 16:29 Tx date 2025-09-30 |
$HLS
HLS Therapeutics Inc. |
Hill, Rodney Graham
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$17,398
+3,246 vol $5.36 each |
||
| Filed 2025-10-07 16:23 Tx date 2025-09-30 |
$HLS
HLS Therapeutics Inc. |
Hill, Rodney Graham
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$17,398
+3,246 vol $5.36 each |
||
| Filed 2025-07-03 13:06 Tx date 2025-06-30 |
$HLS
HLS Therapeutics Inc. |
Hill, Rodney Graham
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$17,075
+3,550 vol $4.81 each |
109,192 | |
| Filed 2025-04-01 12:04 Tx date 2025-03-31 |
$HLS
HLS Therapeutics Inc. |
Hill, Rodney Graham
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$17,895
+3,933 vol $4.55 each |
105,642 | |
| Filed 2025-01-03 15:24 Tx date 2024-12-31 |
$HLS
HLS Therapeutics Inc. |
Hill, Rodney Graham
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$17,948
+4,761 vol $3.77 each |
101,709 | |
| Filed 2024-10-03 09:50 Tx date 2024-09-30 |
$HLS
HLS Therapeutics Inc. |
Hill, Rodney Graham
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$16,882
+4,638 vol $3.64 each |
96,948 | |
| Filed 2024-07-05 10:20 Tx date 2024-06-30 |
$HLS
HLS Therapeutics Inc. |
Hill, Rodney Graham
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$17,107
+5,017 vol $3.41 each |
92,310 | |
| Filed 2024-04-01 14:08 Tx date 2024-03-31 |
$HLS
HLS Therapeutics Inc. |
Hill, Rodney Graham
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$16,936
+4,457 vol $3.80 each |
87,293 | |
| Filed 2024-03-25 13:52 Tx date 2024-03-25 |
$HLS
HLS Therapeutics Inc. |
Hill, Rodney Graham
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$203,114
+49,783 vol $4.08 each |
82,836 | |
| Filed 2022-12-16 16:12 Tx date 2022-12-12 |
$HLS
HLS Therapeutics Inc. |
Hill, Rodney Graham
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$204,040
+20,182 vol $10.11 each |
33,053 | |
| Filed 2021-12-13 17:09 Tx date 2021-12-08 |
$HLS
HLS Therapeutics Inc. |
Hill, Rodney Graham
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$191,520
+12,871 vol $14.88 each |
12,871 | |
| Filed 2021-12-13 17:09 Tx date 2018-03-12 |
$HLS
HLS Therapeutics Inc. |
Hill, Rodney Graham
4 - Director of Issuer
Direct Ownership
|
DSU
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-11-13 12:32 Tx date 2020-11-09 |
$HLS
HLS Therapeutics Inc. |
Hill, Rodney Graham
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$155,600
+10,000 vol $15.56 each |
30,254 | |
| Filed 2019-06-11 10:45 Tx date 2019-06-07 |
$HLS
HLS Therapeutics Inc. |
Hill, Rodney Graham
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$181,857
+11,695 vol $15.55 each |
20,254 | |
| Filed 2018-08-23 Tx date 2018-08-22 |
$HLS
HLS Therapeutics Inc. |
Hill, Rodney Graham
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$71,382
+8,559 vol $8.34 each |
8,559 | |
| Filed 2018-08-23 Tx date 2018-03-12 |
$HLS
HLS Therapeutics Inc. |
Hill, Rodney Graham
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|